Compared to Semaglutide and Tirzepatide, retatrutide's special inclusion of glucagon receptor agonism along with GIP and GLP-one receptor agonism delivers a distinct pharmacological profile. Though Semaglutide can be a GLP-one receptor agonist and Tirzepatide brings together GLP-1 and GIP receptor agonism, retatrutide's triple system could potentially provide broader metabolic Gains. https://franko765evk4.wikitelevisions.com/user